Phosphorylation of beta-actin by protein kinase C-delta in camptothecin analog-induced leukemic cell apoptosis

Shuang Wang1, Ying Zheng, Yun Yu

  • 1Department of Pathophysiology, Xiangya Medical College, Central South University, Changsha, China.

Acta Pharmacologica Sinica
|December 27, 2007
PubMed
Abstract

Insights

This study reveals that beta-actin phosphorylation increases during acute myeloid leukemia (AML) cell apoptosis, mediated by protein kinase C-delta (PKC delta) activation and leading to reduced actin polymerization.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • Understanding the molecular mechanisms of AML cell apoptosis is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify novel proteins involved in acute myeloid leukemia (AML) cell apoptosis.
  • To investigate the role of beta-actin modulation during apoptosis induction.

Main Methods:

  • Differential proteomic analysis of U937 cells induced to undergo apoptosis using camptothecin analog NSC606985.
  • Two-dimensional electrophoresis (2-DE) and immunoblot analysis to assess beta-actin modifications.
  • Enzyme assays to confirm phosphorylation and assess actin polymerization.

Main Results:

  • Beta-actin exhibited altered phosphorylation patterns during apoptosis, with increased phosphorylation observed.
  • A decrease in actin polymerization was noted following NSC606985 treatment.
  • Inhibition of protein kinase C-delta (PKC delta) by rottlerin reversed the observed changes in beta-actin phosphorylation and actin polymerization.

Conclusions:

  • Beta-actin phosphorylation, mediated by activated PKC delta, plays a significant role in AML cell apoptosis.
  • The findings suggest a novel pathway involving beta-actin dynamics in the apoptotic process of AML cells.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...